ZedoarondiolCAS# 98644-24-7 |
- Isozedoarondiol
Catalog No.:BCN9454
CAS No.:108887-68-9
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 98644-24-7 | SDF | Download SDF |
| PubChem ID | 24834047 | Appearance | Cryst. |
| Formula | C15H24O3 | M.Wt | 252.4 |
| Type of Compound | Sesquiterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (3R,3aS,8S,8aR)-3,8-dihydroxy-3,8-dimethyl-5-propan-2-ylidene-1,2,3a,4,7,8a-hexahydroazulen-6-one | ||
| SMILES | CC(=C1CC2C(CCC2(C)O)C(CC1=O)(C)O)C | ||
| Standard InChIKey | TXIKNNOOLCGADE-OSRDXIQISA-N | ||
| Standard InChI | InChI=1S/C15H24O3/c1-9(2)10-7-12-11(5-6-14(12,3)17)15(4,18)8-13(10)16/h11-12,17-18H,5-8H2,1-4H3/t11-,12+,14-,15+/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Zedoarondiol has anti-inflammatory activity, inhibits iNOS, COX-2, and pro-inflammatory cytokine expressions by suppressing the phosphorylations of IKK and MAPKs, and by subsequently inactivating the NF-kappaB pathway. 2. Zedoarondiol dose-dependently inhibits LPS-stimulated nitric oxide (NO), prostaglandin E(2) (PGE(2)), tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1beta (IL-1beta) productions in RAW 264.7 macrophage and in mouse peritoneal macrophage cells. |
| Targets | NOS | COX | NF-kB | IkB | NO | PGE | IL Receptor | TNF-α | ERK | p38MAPK | JNK | IKK |
Zedoarondiol Dilution Calculator
Zedoarondiol Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.962 mL | 19.8098 mL | 39.6197 mL | 79.2393 mL | 99.0491 mL |
| 5 mM | 0.7924 mL | 3.962 mL | 7.9239 mL | 15.8479 mL | 19.8098 mL |
| 10 mM | 0.3962 mL | 1.981 mL | 3.962 mL | 7.9239 mL | 9.9049 mL |
| 50 mM | 0.0792 mL | 0.3962 mL | 0.7924 mL | 1.5848 mL | 1.981 mL |
| 100 mM | 0.0396 mL | 0.1981 mL | 0.3962 mL | 0.7924 mL | 0.9905 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Nitrocaramiphen hydrochloride
Catalog No.:BCC6655
CAS No.:98636-73-8
- Sarmentocymarin
Catalog No.:BCN7489
CAS No.:98633-61-5
- (S)-(-)-Bay K 8644
Catalog No.:BCC7108
CAS No.:98625-26-4
- Schisandrone
Catalog No.:BCN3316
CAS No.:98619-25-1
- Cryptanoside A
Catalog No.:BCN7481
CAS No.:98570-81-1
- Sominone
Catalog No.:BCN8006
CAS No.:98569-64-3
- 4-Chloro-6-iodoquinazoline
Catalog No.:BCC8703
CAS No.:98556-31-1
- Methyl 2-bromomethyl-3-nitrobenzoate
Catalog No.:BCC9035
CAS No.:98475-07-1
- Pseudoginsenoside RT5
Catalog No.:BCN1076
CAS No.:98474-78-3
- Pseudoginsenoside RT1
Catalog No.:BCN2794
CAS No.:98474-74-9
- Myelin Basic Protein (68-82), guinea pig
Catalog No.:BCC1020
CAS No.:98474-59-0
- Metoprolol Succinate
Catalog No.:BCC6519
CAS No.:98418-47-4
- Methyl ganoderate H
Catalog No.:BCN3258
CAS No.:98665-11-3
- Ganoderic acid F
Catalog No.:BCN3037
CAS No.:98665-14-6
- Ganoderic Acid J
Catalog No.:BCN8436
CAS No.:100440-26-4
- Lucidenic acid D2
Catalog No.:BCN8202
CAS No.:98665-16-8
- Ganoderic acid H
Catalog No.:BCN3038
CAS No.:98665-19-1
- Ganoderic acid I
Catalog No.:BCN2865
CAS No.:98665-20-4
- Ganolucidic acid A
Catalog No.:BCN2444
CAS No.:98665-21-5
- Ganoderic acid G
Catalog No.:BCN2915
CAS No.:98665-22-6
- Dregeoside Da1
Catalog No.:BCN4764
CAS No.:98665-65-7
- Dregeoside Ga1
Catalog No.:BCN4548
CAS No.:98665-66-8
- ATP disodium salt
Catalog No.:BCC5160
CAS No.:987-65-5
- Ropivacaine HCl
Catalog No.:BCC4841
CAS No.:98717-15-8
Zedoarondiol isolated from the rhizoma of Curcuma heyneana is involved in the inhibition of iNOS, COX-2 and pro-inflammatory cytokines via the downregulation of NF-kappaB pathway in LPS-stimulated murine macrophages.[Pubmed:19398040]
Int Immunopharmacol. 2009 Aug;9(9):1049-57.
Several sesquiterpene lactones that have been isolated from medicinal plants are known to have many pharmacological activities. In this study, we investigated the anti-inflammatory effects of Zedoarondiol, a sesquiterpene lactone isolated from the rhizoma of Curcuma heyneana, in lipopolysaccharide (LPS)-stimulated macrophage cells. Zedoarondiol dose-dependently inhibited LPS-stimulated nitric oxide (NO), prostaglandin E(2) (PGE(2)), tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1beta (IL-1beta) productions in RAW 264.7 macrophage and in mouse peritoneal macrophage cells. Consistent with these findings, in RAW 264.7 cells, Zedoarondiol suppressed the LPS-stimulated protein levels of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) and the mRNA expressions of iNOS, COX-2, TNF-alpha, IL-6, and IL-1beta in a concentration-dependent manner. Moreover, molecular data revealed that Zedoarondiol inhibited LPS-stimulated DNA binding activity and the transcription activity of nuclear factor-kappa B (NF-kappaB), and this effect was accompanied by decreases in the degradation and phosphorylation of inhibitory kappaB (IkappaB)-alpha, and in the subsequent blocking of NF-kappaB translocations to the nucleus. Furthermore, Zedoarondiol attenuated the phosphorylations of IkappaB kinase (IKK), extracellular signal-regulated kinase (ERK), p38 mitogen-activated protein kinase (p38), and c-Jun N-terminal kinase (JNK) in LPS-stimulated RAW 264.7 cells. Taken together, the findings of the present study indicate that Zedoarondiol inhibits iNOS, COX-2, and pro-inflammatory cytokine expressions by suppressing the phosphorylations of IKK and MAPKs, and by subsequently inactivating the NF-kappaB pathway. These relations reveal, in part, the mechanism underlying the anti-inflammatory properties of Zedoarondiol.
